Skip to main content
Clinical Trials/JPRN-jRCTs042210010
JPRN-jRCTs042210010
Recruiting
未知

Study of the impact of the Flash Glucose Monitoring System (FGM) on glycometabolism of newly diagnosed type 2 diabetic patients

Arima Hiroshi0 sites60 target enrollmentApril 21, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
type 2 diabetes mellitus
Sponsor
Arima Hiroshi
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diabetes patients who
  • 1\)are diagnosed type 2 diabetes mellitus
  • 2\)have HbA1c level of 7\.0% or more and less than 8\.0%
  • 3\)are 20 years of age or older
  • 4\) are not prescribed any hypoglycemic drug

Exclusion Criteria

  • Those who have hyperglycaemic symptoms or ketosis
  • Those whose anti\-GAD Abs are positive
  • Those who have been using self\-monitaring of blood glucose
  • THose who have preproliferative or proliferative diabetic retinopathy
  • Those who have severe renal failure (eGFR\<30/ml/min/1\.73m3\)
  • Those who are judged by their physicians to be unsuitable for enrolling the study

Outcomes

Primary Outcomes

Not specified

Similar Trials